Using Meta-Analysis to Study Drug Safety and Efficacy
JUN 19, 2017 | CONTAGION® EDITORIAL STAFF
Khalid Eljaaly, PharmD, MS, CAPPS, BCPS, Contagion® Editorial Advisory Board member, postdoctoral research fellow on infectious diseases and antimicrobial stewardship, MS student in clinical translational sciences, the University of Arizona, College of Pharmacy, explains which studies are ideal to run through a meta-analysis.
Interview Transcript (slightly modified for readability)
“The strongest types of meta-analyses are those of randomized clinical trials, especially [those] of good quality. If I [am able] to do a meta-analysis of those studies, that would be stronger. However, sometimes we don’t have those randomized clinical trials.
For example, one of the topics of great interest these days [on which] a lot of studies are being published [is] related to two old medications – cefazolin and antistaphylococcal penicillins. We used to use these drugs for years, but [only] recently, [are most of these] studies getting published. I remember [at] one of the conferences last year there [were] seven posters about the same topic. In that case, it would be of interest to do a meta-analysis and pull the results together to help understand how these two drugs are different.
One study is unlikely to tell us the exact answer [for] all questions; most often, those studies are of small sample size, they are [too] underpowered to detect a difference, if it exists. So, by doing a meta-analysis, if it’s well-designed, it might tell us if one drug is more toxic than the other one, if one drug is more effective than the other one, and if [this is the case] in all types of situations, or can we pull the results of 30 [different] populations and see if this drug works better than the other drug in this population.”
To stay informed on the latest in infectious disease news and developments, please sign upfor our weekly newsletter.
The new test can differentiate between Lyme disease and 7 other tick-borne diseases.
Contagion® is a fully integrated news resource covering all areas of infectious disease. Through our website, quarterly journal, email newsletters, social media outlets, and Outbreak Monitor we provide practitioners and specialists with disease-specific information designed to improve patient outcomes and assist with the identification, diagnosis, treatment, and prevention of infectious diseases. Our mission is to assure that the healthcare community and public have the knowledge to make more informed choices and have a positive impact on patient outcomes.
2 Clarke Drive
Cranbury, NJ 08512